Drug Delivery Design and Development
Accelerating Drug Delivery Device Development for Pharma and Device Companies
We are an award winning medical product development consultancy that works with pharmaceutical and device teams to solve their complex engineering challenges, helping to select and develop effective drug delivery devices, from parenteral systems for complex biologics, to precision devices for targeted therapies.
With over 25 years of medical device experience, we combine science, engineering, human-centered design and manufacturing expertise to solve delivery challenges, reduce technical uncertainty and accelerate programs.
We work with device teams at the world’s largest pharmaceutical companies, where our work spans technology landscaping, technical due diligence on drug delivery systems, roadmapping, and device development. Our expertise covers parenteral high-viscosity and high volume formulations, and emerging precision delivery devices, where we define requirements, develop devices and build evidence to support milestones including first-in-human clinical trials.
Technology landscaping and due diligence
Make informed choices about your delivery technology.
We assess available systems against your formulation, intended use and development priorities. Technology landscaping identifies suitable options, while technical due diligence examines platform performance, supplier evidence and development risks, weighing these against the commercial opportunity.
Our findings inform device selection and a clear development roadmap.
- Map and compare available technologies.
- Assess performance and formulation compatibility.
- Identify evidence gaps and technical risks.
- Recommend testing and development priorities.
Human factors and user-centered design
Design for the people using your device.
We study how patients, caregivers and healthcare professionals interact with drug delivery devices. User research informs requirements and design decisions, while usability testing identifies difficulties and use-related risks throughout development.
Our findings guide improvements from preparation through to disposal.
- Understand users and environments of use.
- Define requirements through user research.
- Evaluate usability and use-related risks.
- Refine designs through feedback and testing.
Precision delivery for complex therapies
Connect your therapy’s delivery needs with the right technology, device requirements and testing strategy.
Our CNS specialists assess delivery options for therapies requiring targeted administration, including cell and gene therapies. We consider anatomy, route of administration and clinical workflow to translate therapeutic needs into practical development requirements.
We combine computational and tissue-based modeling with engineering and physical testing to investigate delivery performance and distribution. This work identifies evidence gaps, guides device development and builds a verification strategy to support progression toward the clinic.
Parenteral delivery for complex therapies
Develop devices around your formulation and the people using them.
Our experience spans autoinjectors, on-body delivery systems and infusion pumps, including challenges involving high-viscosity biologics, high-volume doses and two-component therapies.
We combine engineering and user-centered design to assess delivery performance, preparation steps and manufacturing requirements. The findings guide technology selection and device development.
Our expertise also extends to specialized routes of administration, including our collaboration with Re-Vana Therapeutics on a novel delivery system for sustained-release ophthalmic formulations.
Drug Delivery Development: From Strategy to Clinical Manufacture
Who are CDP's clients for drug delivery development?
We work with pharmaceutical, biotech, CDMO and medical device teams developing therapies and delivery systems. Our projects range from standalone technology assessments to integrated device development programs, bringing together engineering, clinical, human factors, and manufacturing expertise.
What types of drug delivery devices does CDP develop?
Our experience includes autoinjectors, pen injectors, inhalation, on-body delivery systems, and infusion pumps, alongside specialized systems for ocular and precision delivery. We work on challenges involving high-viscosity formulations, high-volume doses and sensitive active ingredients.
Can CDP independently assess existing drug delivery platforms?
Yes. We provide technology landscaping, assessment and technical due diligence to inform platform selection. We review available evidence against your formulation, delivery requirements and development priorities, identifying limitations and evidence gaps. With specialist in-house testing and verification capability, we can lead on further testing needs to generate the data to support decision making.
Can we work with CDP on just one development stage?
Yes. We support standalone assessments and individual development stages, as well as integrated programs. Projects can focus on a specific need, such as feasibility testing, human factors, device engineering or pilot manufacturing for clinical trials.
What areas of drug delivery does CDP specialize in?
We specialize in developing devices for complex delivery challenges, including parenteral systems for high-viscosity biologics, high-volume doses and two-component therapies, and precision delivery systems for targeted therapies, including cell and gene therapies. Our expertise combines formulation and device assessment, engineering, human factors and testing, with dedicated specialists in CNS delivery.
Defining Your Device Development Priorities
We work with your team to connect therapy requirements, user needs and commercial priorities with a practical development plan. Whether you are selecting a platform or developing a new delivery system, we identify the questions, risks and evidence needs that matter for your next milestone.
Integrated Design, Prototyping and Testing
Our designers, engineers and testing specialists work together to rapidly turn concepts into prototypes that answer development questions. From handling models to functional systems, we evaluate usability and technical performance, using the findings to refine the design and address risks as your drug delivery device develops.
Capabilities
Positioned for Innovation
Located at the heart of innovation in Cambridge, UK, and Raleigh, North Carolina, our bases are strategically positioned to tap into the world’s leading research and development communities.
ISO-Certified Management System
To support our product development and prototype manufacturing services, CDP’s Quality Management System is certified to ISO 13485:2016 by Intertek Medical Notified Body and ISO 9001:2015 by Intertek Certification Ltd. We are also certified to ISO 27001:2022 by Intertek Certification Ltd to support the maintenance of the confidentiality, availability and integrity of our clients data.
Client-Centric Intellectual Property Approach
Our clients fully own all intellectual property we help create. We equip them with the tools and knowledge to enable lasting independence.
Advancing Injectable Drug Delivery Systems
Unlock expert opinions and insights with four in-depth interviews on the challenges of parenteral innovation.
Breathing New Life: Industry Insights into the future of Respiratory Drug Delivery
Discover the exciting possibilities on the horizon for inhalation device design with our latest resource. This e-book explores recent advancements and highlights innovative strategies crucial for developing significant new treatments.
Meet The Team
Featured Insights